IP Library Granted Patent US 7,247,433
Granted Patent B2
US 7,247,433 · App. 10/486,564 · Granted Jul 24, 2007

Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles

Assignee: University of Rochester
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,247,433
App. No.
10/486,564
Granted
Jul 24, 2007
Kind
B2
Abstract

The present invention relates to a method of vaccinating a mammal against papillomavirus by administering papillomavirus virus-like particles transdermally to a mammal under conditions effective to induce an immune response to the papillomavirus.

Claims (15)

1. A method of inducing an immune response in a mammal against papillomavirus comprising:

administering papillomavirus virus-like particles transcutaneously to a mammal under conditions effective to induce an immune response to the papillomavirus.

2. The method according to claim 1 further comprising:

administering one or more vaccine booster inoculations of papillomavirus virus-like particles to the mammal.

3. The method according to claim 2 , wherein said booster inoculation is administered parenterally, transdermally, or orally.

4. The method according to claim 3 , wherein the booster is orally administered.

5. The method according to claim 3 , wherein the booster is parenterally administered.

6. The method according to claim 3 , wherein the booster is transdermally administered.

7. The method according to claim 1 , wherein the immune response is an immune response which will protect the mammal from infection by papillomavirus.

8. The method according to claim 1 , wherein the papillomavirus is a human papillomavirus.

9. The method according to claim 8 , wherein the human papillomavirus is Human Papillomavirus Type 6.

10. The method according to claim 8 , wherein the human papillomavirus is Human Papillomavirus Type 11.

11. The method according to claim 8 , wherein the human papillomavirus is Human Papillomavirus Type 16.

12. The method according to claim 8 , wherein the human papillomavirus is Human Papillomavirus Type 18.

13. The method according to claim 8 , wherein the papillomavirus virus-like particles are administered with a pharmaceutically acceptable carrier.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 18, 2008
From: UNIVERSITY OF ROCHESTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021546/0764 →
CONFIRMATORY LICENSE Recorded Sep 18, 2008
From: UNIVERSITY OF ROCHESTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021547/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2004
From: ROSE, ROBERT C.
To: ROCHESTER, UNIVERSITY OF
Reel/Frame 015715/0906 →
Continuity (3)
Provisional Application 6037702300 · May 1, 2002
Provisional Application 6031190100 · Aug 13, 2001
Related Publication 20050013832A1 · Jan 20, 2005